共 22 条
[2]
In-vitro analysis of the contribution of CYP2D6.35 to ultrarapid metabolism
[J].
PHARMACOGENETICS,
2001, 11 (08)
:739-741
[3]
DAHL ML, 1995, J PHARMACOL EXP THER, V274, P516
[6]
Polymorphisms in CYP2D6 duplication-negative individuals with the ultrarapid metabolizer phenotype:: a role for the CYP2D6*35 allele in ultrarapid metabolism?
[J].
PHARMACOGENETICS,
2001, 11 (01)
:45-55
[7]
Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: Characterization of 48 mutations and 53 alleles, their frequencies and evolution
[J].
PHARMACOGENETICS,
1997, 7 (03)
:193-202
[8]
MULLER B, 2001, CLIN CHEM, V47, pA240
[9]
Prospective GYP2D6 genotyping as an exclusion criterion for enrollment of a phase III clinical trial
[J].
PHARMACOGENETICS,
2000, 10 (07)
:583-590
[10]
Elucidation of the genetic basis of the common 'intermediate metabolizer' phenotype for drug oxidation by CYP2D6
[J].
PHARMACOGENETICS,
2000, 10 (07)
:577-581

